Investing in Scientific Research

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Investing is part of the mandate at general catalist. You want to be patient, but impatient right? Like you don't want to waste resources. But we've seen some technologies that struggled for years to get traction, and then suddenly became critical. In the case of m r and a, m r a had been used in other disease contects unsuccessfully, but for single strandana like covet 19,. it turns out to be perfect for that. The same with imuna oncology. For years, people are very sceptical about it. So people often say, in te tech field, you want to fail fast. And so you want to continue to function, or

Ken Frazier, the longtime CEO of pharmaceutical giant Merck, was one of the few Black CEOs at the top of Corporate America. Now as an adviser at General Catalyst and co-founder of the social impact organization OneTen, he’s re-shaping how business addresses racial and health equity. He joins host Bob Safian to discuss crisis adjustment, the positive side of fear, and the importance of vulnerability. Plus, he addresses the rising divisiveness in American culture, and the important role that business can play – by stressing our commonality and emphasizing kindness.

Read a transcript of this episode: https://mastersofscale.com

Subscribe to the Masters of Scale weekly newsletter: https://mastersofscale.com/subscribe

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.